“If this blog helped you out, don’t keep it to yourself—share the link on your socials!” 👍 “Like what you read? Spread the love and share this blog on your social media.” 👍 “Found this useful? Hit share and let your friends know too!” 👍 “If you enjoyed this post, please share the URL with your friends online.” 👍 “Sharing is caring—drop this link on your social media if it helped you.”

Monday, August 25, 2025

Vifor Pharma


Vifor Pharma – Product Catalog

Iron Deficiency & Anemia

  • Ferinject / Injectafer (U.S.) → Generic: ferric carboxymaltose → Indication: Iron deficiency anemia (IDA) → Dose: IV infusion 50 mg/mL (750–1000 mg per dose)

  • Venofer → Generic: iron sucrose → Indication: Iron deficiency anemia in CKD (on dialysis or not) → Dose: IV infusion 20 mg/mL (100–200 mg per infusion)

  • Maltofer → Generic: ferric maltol (oral iron) → Indication: Iron deficiency anemia (oral alternative) → Dose: Tablets/capsules 30 mg

Nephrology & Dialysis

  • Velphoro → Generic: sucroferric oxyhydroxide → Indication: Hyperphosphatemia in CKD patients on dialysis → Dose: Chewable tablets 500 mg

  • Veltassa → Generic: patiromer sorbitex calcium → Indication: Hyperkalemia (chronic potassium binding) → Dose: Oral powder packets 8.4 g, 16.8 g, 25.2 g

  • Mircera (licensed from Roche) → Generic: methoxy polyethylene glycol-epoetin beta → Indication: Anemia due to CKD → Dose: SC/IV injection 30–250 mcg

Rare & Specialty

  • Avacopan (Tavneos – partner with ChemoCentryx) → Generic: avacopan → Indication: ANCA-associated vasculitis → Dose: Capsules 30 mg bid

  • Korsuva (licensed) → Generic: difelikefalin → Indication: Moderate-to-severe pruritus in hemodialysis patients → Dose: IV injection 0.5 mcg/kg after dialysis

Other Iron Products

  • CosmoFer → Generic: iron dextran (low molecular weight) → Indication: Iron deficiency when oral iron is unsuitable → Dose: IV or IM injection 50 mg/mL

  • MonoFer → Generic: ferric derisomaltose → Indication: Iron deficiency anemia → Dose: IV infusion, up to 1000–1500 mg per infusion



No comments:

Post a Comment